Loading insider details...
Latest Form 4 (Sep 2, 2026): Grant/Award of 5,943 ERNA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Ernexa Therapeutics Inc. (ERNA) | Grant/Award | 5,943 | n/a |
| Feb 10, 2025 | Eterna Therapeutics Inc. (ERNA) | Grant/Award | 124,533 | n/a |
| Aug 3, 2022 | Brooklyn ImmunoTherapeutics, Inc. (BTX) | Grant/Award | 152,100 | n/a |